Termination of Pregnancy Clinical Trial
Official title:
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.
This study will investigate the uptake of mifepristone administration outside of the health center for pregnancy termination and its acceptability to women and to their providers. In addition, we plan to evaluate rates of follow-up, adherence, efficacy, complications, days of missed work and/or school, and lost income. This will be a prospective, comparative, non-randomized, open-label study. All women who are seeking medical abortion will be offered participation in the study. Women who enroll in the study will be given a choice between taking the mifepristone outside the center or in the center setting. ;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05326854 -
NAVIGATION ASSISTED CARE PROGRAM AND TERMINATION OF PREGNANCY
|
N/A | |
Completed |
NCT04602052 -
Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia
|
N/A | |
Completed |
NCT00994734 -
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
|
N/A | |
Not yet recruiting |
NCT04303949 -
Multi-Media E-Book for Second‐Trimester Termination Due to Fetal Anomaly
|
N/A | |
Completed |
NCT04910958 -
Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy
|
||
Completed |
NCT03393455 -
Obstetric & Pediatric Evolution Following Parental Refusal for Early Termination of Pregnancy Despite Fetal Risk
|
||
Completed |
NCT03877900 -
A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital
|
||
Completed |
NCT02597699 -
Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide
|
Phase 3 | |
Enrolling by invitation |
NCT03494842 -
TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies
|
N/A | |
Completed |
NCT03802149 -
Ulipristal Acetate for Cervical Preparation
|
Early Phase 1 |